Key facts
- Avkin’s last known valuation is $2.1M (Jan 2022).
- It has raised $3.3M; the latest was Later Stage VC ($300K) in Dec 2024.
- Notable investors include Annarie Lyles, Jumpstart NJ Angel Network, Martinson Ventures, University of Delaware.
- Status: Privately Held (backing).
- ·The complete investor list — 4 names
- ·Watchlist + deal alerts for Avkin
- ·The full record, as it builds
Funding rounds
No funding rounds for Avkin are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Avkin
Manufacturer of wearable healthcare technology intended to augment standardized healthcare simulation education experience. The company's technology permits nurses to perform surgical simulations on live actors by offering synthetic models of human bodies, enabling healthcare professionals to perform invasive procedures using wearable technology and receive haptic feedback on their procedures.
- Sector
- Healthcare
- HQ
- Newport, DE, United States
- Founded
- 2015
- Employees
- 36
- Website
- avkin.com/
- Ownership
- Privately Held (backing)
Avkin doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Avkin shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Avkin in its N-PORT filings yet. We sweep new filings monthly.